Business · 07/06/2019Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance on Enhancing Clinical Trial Diversity
Summary
The FDA has released a draft guidance to encourage pharmaceutical companies to increase diversity in their clinical trials by broadening eligibility criteria and enrolling underrepresented populations.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →